Abstract
AbstractPeptides, which are made up of amino acids, are an excellent candidate as a composition component of a nanocarrier for drug delivery due to their biocompatibility, bioavailability, and stability in vivo. Here, the progress in peptides as nanocarriers for applications in cancer therapy are summarized, including as a nanocarrier matrix for self‐assembled nanoparticles, as surface modification moieties of nanocarriers for targeting and/or penetrating function, and as enzyme‐responsive linkers of nanoparticles for triggering drug release. Peptide‐based nanocarriers should receive more attention, and they have great potential in biomedical applications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
